Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03LAL
|
|||
| Former ID |
DIB014175
|
|||
| Drug Name |
RBBX-01
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Barros Research Institute
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Phase I study and preliminary pharmacology of the novel innate immune modulator rBBX-01 in gynecologic cancers. Clin Cancer Res. 2008 May 15;14(10):3089-97. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.